We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 8,023 results
  1. Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial

    Optimal conditioning prior to allogeneic hematopoietic stem cell transplantation for children with non-malignant diseases is subject of ongoing...

    Karl-Walter Sykora, Rita Beier, ... Krzysztof Kalwak in Bone Marrow Transplantation
    Article Open access 04 November 2023
  2. Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation

    Allogeneic hematopoietic cell transplantation (HCT) offers a possible cure for patients with relapsed and refractory non-Hodgkin lymphoma (NHL)...

    Kimimori Kamijo, Yoshimitsu Shimomura, ... Eisei Kondo in Annals of Hematology
    Article Open access 12 January 2023
  3. Population Pharmacokinetic Model of Intravenous Busulfan in Hematopoietic Cell Transplantation: Systematic Review and Comparative Simulations

    Background

    Busulfan is commonly used in the chemotherapy prior to hematopoietic cell transplantation (HCT). Busulfan has a narrow therapeutic window...

    Takuto Takahashi, Mutaz M. Jaber, ... Mahmoud Al-Kofahi in Clinical Pharmacokinetics
    Article 06 July 2023
  4. Busulfan

    Article 06 July 2024
  5. Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiday therapeutic drug monitoring regimen

    Busulfan exposure has previously been linked to clinical outcomes, hence the need for therapeutic drug monitoring (TDM). Study objective was to...

    T. (Tim) Bognàr, J. S. (Jurjen) Kingma, ... A. (Arief) Lalmohamed in Bone Marrow Transplantation
    Article 31 March 2023
  6. Busulfan

    Article 11 May 2024
  7. Modeling methods for busulfan-induced oligospermia and asthenozoospermia in mice: a systematic review and meta-analysis

    Objective

    Modeling methods for busulfan-induced oligoasthenozoospermia are controversial. We aimed to systematically review the modeling method of...

    Ruiyang Pu, **g Liu, ... Ning Cheng in Journal of Assisted Reproduction and Genetics
    Article 12 December 2022
  8. Busulfan

    Article 28 October 2023
  9. Busulfan/posaconazole

    Article 24 February 2024
  10. Busulfan

    Article 27 May 2023
  11. Busulfan/imatinib

    Article 29 July 2023
  12. Busulfan/melphalan

    Article 10 June 2023
  13. Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan

    Although exposure-directed busulfan (BU) dosing can improve allogeneic hematopoietic stem cell transplantation outcomes, there is still large...

    Tomoki Iemura, Tadakazu Kondo, ... Akifumi Takaori-Kondo in Annals of Hematology
    Article 13 April 2023
  14. Evaluation of different pharmacokinetically guided IV busulfan exposure ranges on adult patient outcomes after hematopoietic stem cell transplantation

    Conditioning intensity contributes significantly to outcomes in allogeneic hematopoietic stem cell transplantation (allo-HSCT). We evaluated two...

    Shahram Mori, Mengni Guo, ... Juan Carlos Varela in Annals of Hematology
    Article 03 December 2022
  15. Ellagic acid effects on testis, sex hormones, oxidative stress, and apoptosis in the relative sterility rat model following busulfan administration

    Background

    Busulfan is an antineoplastic medication that is broadly utilized for cancer treatment. It affects the testicular function and leads to...

    Amirabbas Rostami, Sina Vakili, ... Saam Noroozi in BMC Complementary Medicine and Therapies
    Article Open access 23 June 2022
  16. Busulfan

    Article 29 October 2022
Did you find what you were looking for? Share feedback.